Specialized AntiViral Solutions

NTVIRIN Pharma Pte Ltd was incorporated in Singapore on 15th January 2024 by a group of professionals and Investment partners with the aim to manufacture NTVIRIN solution in Singapore and produce own drugs to cure diseases such as HUMAN RESPIRATORY SYNCYTICAL VIRUS DISEASES, SWINE FLU, HUMAN RENOVIRUS-17 DISEASES, DENGUE FEVER, PROSTATE CANCER, Etc. NTVIRIN stands at the forefront of pharmaceutical innovation through fifteen years of dedicated research by a group of scientist in the development of anti-viral and anti-cancer drugs. It is rooted in global standards and driven by a commitment to excellence, we strive to re-define healthcare solutions, in manufacture of zero – cytotoxic drugs. We Syntheses the NTVIRIN compound/solution through proprietary technology in Aqueous form and ready to use. It has zero cytotoxic and hence no side effects or post viral causes for the patients. Compatible Active Pharmaceutical Ingredient and positioned as nonsterile Active Pharmaceutical Ingredient (API),